Yes, boldenone (Equipoise) significantly increases cholesterol levels and negatively impacts overall lipid profiles, similar to other anabolic-androgenic steroids (AAS). Here's a breakdown of its effects:
1.Decreases HDL ("Good") Cholesterol: This is the most consistent and pronounced effect. Boldenone suppresses HDL levels, often dramatically. Studies and user bloodwork frequently show HDL reductions of 30-60% or more. Low HDL is a major risk factor for atherosclerosis (hardening of the arteries).
2.Increases LDL ("Bad") Cholesterol: Boldenone tends to increase LDL cholesterol levels. Elevated LDL directly contributes to plaque buildup in arteries.
3.Worsens HDL:LDL Ratio: The combined effect of lowering HDL and raising LDL results in a significantly worsened cholesterol ratio, which is a strong predictor of cardiovascular disease risk.
4.May Increase Triglycerides: Some users report increases in triglyceride levels, although this effect can be more variable.
Why does this happen?
●Hepatic Lipase Activity: AAS like boldenone increase the activity of the enzyme hepatic lipase, which breaks down HDL particles.
●Altered Lipid Metabolism: Steroids disrupt the normal production, transport, and clearance of cholesterol and triglycerides in the liver and bloodstream.
●Reduced ApoA-I Production: They can decrease production of apolipoprotein A-I (ApoA-I), a key component of HDL.
Important Considerations:
●Dose-Dependent & Duration-Dependent: The negative impact on cholesterol is generally worse with higher doses and longer cycles.
●Individual Variation: Genetics, diet, exercise habits, and overall health influence the severity of the effect.
●Compared to Other Steroids: While often perceived as "gentler" than some steroids (like oral 17-alpha-alkylated ones or trenbolone) regarding liver toxicity, its negative impact on lipids is still significant and well-documented. Some users report slightly less severe lipid disruption than with certain other injectables like trenbolone, but it's still a major concern.
●Long-Term Risks: Persistently unfavorable lipid profiles significantly increase the risk of cardiovascular events like heart attack and stroke, especially with prolonged or repeated use.
●Recovery: Lipid profiles often improve after stopping boldenone, but recovery can be slow (months), and long-term damage may persist depending on usage history and individual factors.
In summary: Yes, boldenone unequivocally increases cardiovascular risk by negatively altering cholesterol levels, primarily through substantial suppression of HDL and elevation of LDL.
Crucial Note: Boldenone is a prescription veterinary medication (not approved for humans) with significant health risks. Non-medical use is illegal and dangerous. If you are considering using AAS for any reason, it is essential to consult with a doctor who understands endocrinology and sports medicine. They can discuss the risks, potential benefits (in rare medical cases), legal alternatives, and crucially, monitor your health (including comprehensive lipid panels) throughout.
https://www.hormonerawsource.com/steroid-finished/steroid-finished-oils/stromusc-boldenolone-undecylenate-bu600-for.html
